CHFS 3.59 grabbed a starter. 625K O/S, Catalysts ahead DD:
1. In the third quarter, CHFS held a scientific advisory board meeting with 6 key physician opinion leaders that provided guidance on protocol design for a mechanistic study and a registry study expected to begin in early 2018. They also hired and trained 6 additional experienced sales professionals and increased the US sales team to 10 territories, up from 4 territories in Q2.
2. it seems, the study which mentioned above (early 2018), will be presented here: CHF Solutions, Inc. to Present at NobleCon 14 on January 29th, 2018
3. solid 10Q, Assets/Liabilities ratio= 4+ which is very solid. Total Assets increased by $2m. net loss cut by a half.
4. the best part: The number of outstanding shares of the registrant’s common stock, $0.0001 par value, as of October 31, 2017 was 625,791
UNREAL THIN
5. Form 4 insider buying January 3rd, 2018 CFO 197,746 shares @ 3.50 COO 181,068 shares @ 3.50
6. Net Assets alone about 3.5 times current market cap. this could be a HUGE mover on the right news.
7. has $15 Price Target
My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.
